·¬ΗΡΙηΗψapp

Meeting Coverage

EASL

European Association for the Study of the Liver

Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV

Persistent viral suppression in most patients, even after 8 years

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Latest EASL Meeting Coverage

Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?

Early model suggests a way to predict progression-free survival

June 26, 2023
Fecal Matter Transplant Shows Promise in Cirrhosis

Pilot trial demonstrates that FMT can boost gut health, prevent serious infections

June 25, 2023
Novel Agent Leads to Fibrosis Improvement in NASH

Phase IIb ENLIVEN trial saw success with various doses of pegozafermin

June 24, 2023
Ukraine's Mobile Medical Teams Duck Rockets

Public health expert describes pivot to provide medical aid in war-torn Ukraine

June 23, 2023
Antiviral Offers 'Glimmer of Hope' in Chronic Hepatitis D

At 48 weeks, bulevirtide led to undetectable HDV RNA, normalization of ALT in up to 48%

June 23, 2023
'Game Changer' in NASH: Resmetirom Hits Endpoints in Pivotal Study

Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis

June 22, 2023
EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2D

Noteworthy research from the European Association for the Study of the Liver annual meeting

June 29, 2022
'A New Hope' for Rare, Deadly Liver Disease

Small fazirsiran trial sees fibrosis regressions for liver disease associated with AAT deficiency

June 28, 2022
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis

Randomized trial showed improvements in cardiometabolic markers, but not liver fibrosis

June 27, 2022
Liver Cirrhosis Tied to Elevated Risk for Stroke

37% higher risk observed in large German study

June 25, 2022
Bulevirtide's Effect Sustained in Difficult-to-Treat Hepatitis D

Nearly half of patients at week 48 had virological and biochemical response

June 25, 2022
German Study Warns of Increasing Acute Hep C Reinfections in MSM

14% of patients experienced a reinfection over the past decade

June 24, 2022
Early Liver Disease Detection Linked to Subsequent Lifestyle Improvements

Danish study shows fibrosis screening associated with improved diet, alcohol use, and exercise

June 24, 2022
Novel Liver Assist Device Safe for Patients With Cirrhosis

Small preliminary trial also shows hints of promising clinical results

June 29, 2021